JP2012521355A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521355A5
JP2012521355A5 JP2012500991A JP2012500991A JP2012521355A5 JP 2012521355 A5 JP2012521355 A5 JP 2012521355A5 JP 2012500991 A JP2012500991 A JP 2012500991A JP 2012500991 A JP2012500991 A JP 2012500991A JP 2012521355 A5 JP2012521355 A5 JP 2012521355A5
Authority
JP
Japan
Prior art keywords
medicament
use according
administered
burns
topically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012500991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012521355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/027953 external-priority patent/WO2010120431A2/en
Publication of JP2012521355A publication Critical patent/JP2012521355A/ja
Publication of JP2012521355A5 publication Critical patent/JP2012521355A5/ja
Pending legal-status Critical Current

Links

JP2012500991A 2009-03-20 2010-03-19 熱傷及び二次性合併症の予防及び治療方法 Pending JP2012521355A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US16206009P 2009-03-20 2009-03-20
US61/162,060 2009-03-20
US24965809P 2009-10-08 2009-10-08
US61/249,658 2009-10-08
US25853309P 2009-11-05 2009-11-05
US61/258,533 2009-11-05
US25934909P 2009-11-09 2009-11-09
US61/259,349 2009-11-09
PCT/US2010/027953 WO2010120431A2 (en) 2009-03-20 2010-03-19 Methods for the prevention and treatment of burn injuries and secondary complications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014211820A Division JP6005707B2 (ja) 2009-03-20 2014-10-16 熱傷及び二次性合併症の予防及び治療方法

Publications (2)

Publication Number Publication Date
JP2012521355A JP2012521355A (ja) 2012-09-13
JP2012521355A5 true JP2012521355A5 (enExample) 2013-05-16

Family

ID=42983062

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2012500991A Pending JP2012521355A (ja) 2009-03-20 2010-03-19 熱傷及び二次性合併症の予防及び治療方法
JP2014211820A Active JP6005707B2 (ja) 2009-03-20 2014-10-16 熱傷及び二次性合併症の予防及び治療方法
JP2016174286A Pending JP2016210801A (ja) 2009-03-20 2016-09-07 熱傷及び二次性合併症の予防及び治療方法
JP2018153359A Pending JP2018172442A (ja) 2009-03-20 2018-08-17 熱傷及び二次性合併症の予防及び治療方法
JP2020150963A Pending JP2020196762A (ja) 2009-03-20 2020-09-09 熱傷及び二次性合併症の予防及び治療方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2014211820A Active JP6005707B2 (ja) 2009-03-20 2014-10-16 熱傷及び二次性合併症の予防及び治療方法
JP2016174286A Pending JP2016210801A (ja) 2009-03-20 2016-09-07 熱傷及び二次性合併症の予防及び治療方法
JP2018153359A Pending JP2018172442A (ja) 2009-03-20 2018-08-17 熱傷及び二次性合併症の予防及び治療方法
JP2020150963A Pending JP2020196762A (ja) 2009-03-20 2020-09-09 熱傷及び二次性合併症の予防及び治療方法

Country Status (5)

Country Link
US (5) US20100331265A1 (enExample)
EP (4) EP2408463B1 (enExample)
JP (5) JP2012521355A (enExample)
CN (2) CN102573881A (enExample)
WO (1) WO2010120431A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573881A (zh) * 2009-03-20 2012-07-11 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法
WO2011025734A1 (en) 2009-08-24 2011-03-03 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
EP2764871A1 (en) 2009-10-05 2014-08-13 Cornell University Methods for the prevention or treatment of heart failure
EP3511012A1 (en) * 2010-02-26 2019-07-17 Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy
EP3290433A1 (en) * 2010-05-03 2018-03-07 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
WO2013049697A1 (en) 2011-09-29 2013-04-04 Mayo Foundation For Medical Education And Research Aromatic-cationic peptides and methods for using same
JP6317324B2 (ja) * 2012-03-30 2018-04-25 ステルス ペプチドズ インターナショナル インコーポレイテッド 神経障害を予防および処置するための方法および組成物
ES2750258T3 (es) * 2013-03-01 2020-03-25 Stealth Biotherapeutics Corp Métodos y composiciones para la prevención o tratamiento del síndrome de Barth
CN117752766A (zh) * 2013-03-01 2024-03-26 康德生物医疗有限公司 治疗线粒体疾病的方法
WO2014209905A2 (en) 2013-06-26 2014-12-31 Stealth Peptides International, Inc. Methods and compositions for detecting and diagnosing diseases and conditions
WO2017117381A1 (en) * 2015-12-31 2017-07-06 Scott Duncan Therapeutic compositions including peptides and uses thereof
JP7038675B2 (ja) * 2016-03-11 2022-03-18 ステルス バイオセラピューティクス インコーポレイテッド 結晶塩形態
WO2017180535A1 (en) * 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
US11426980B2 (en) 2018-08-23 2022-08-30 Sekisui Chemical Co., Ltd. Interlayer for laminated glass, laminated glass, and glass structure

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP0350221B1 (en) * 1988-06-30 1996-04-17 Astra Aktiebolag Dermorphin analogs, their methods of preparation, pharmaceutical compositions, and methods of therapeutic treatment using the same
US5602100A (en) * 1988-06-30 1997-02-11 Astra Ab Dermorphin analogs having pharmacological activity
US5674980A (en) * 1989-12-21 1997-10-07 Biogen Inc Fusion protein comprising tat-derived transport moiety
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5716644A (en) * 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5674534A (en) * 1992-06-11 1997-10-07 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
EP0747092B1 (en) * 1995-06-09 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Matrix for iontophoresis
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5885958A (en) * 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
WO1999029721A1 (en) * 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
US6268398B1 (en) * 1998-04-24 2001-07-31 Mitokor Compounds and methods for treating mitochondria-associated diseases
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
SE9900961D0 (sv) * 1999-03-16 1999-03-16 Astra Ab Novel compounds
AU7880700A (en) * 1999-08-16 2001-03-13 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric
WO2001025188A1 (en) * 1999-10-04 2001-04-12 University Of Medicine And Dentistry Of New Jersey Novel carbamates and ureas
US6759520B1 (en) * 1999-10-28 2004-07-06 The New England Medical Center Hospitals, Inc. Chimeric analgesic peptides
US20050192215A1 (en) * 2000-01-21 2005-09-01 Malabika Ghosh Methods and materials relating to novel polypeptides and polynucleotides
CA2416475C (en) * 2000-07-18 2011-10-11 Cornell Research Foundation, Inc. Medicinal uses of mu-opioid receptor agonists
US6900178B2 (en) * 2000-09-12 2005-05-31 University Of Kentucky Research Foundation Protection against ischemia and reperfusion injury
US20070015146A1 (en) 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
JP2006505290A (ja) * 2002-11-10 2006-02-16 インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法
ES2436011T3 (es) * 2003-02-04 2013-12-26 Cornell Research Foundation, Inc. Métodos para prevenir la transición de la permeabilidad mitocondrial
CN100506841C (zh) * 2003-05-01 2009-07-01 科内尔研究基金会 将分子递送到细胞的方法和载体复合物
AU2004274013A1 (en) * 2003-09-17 2005-03-31 Icos Corporation Use of Chk1 inhibitors to control cell proliferation
US7232824B2 (en) * 2003-09-30 2007-06-19 Scios, Inc. Quinazoline derivatives as medicaments
RU2376028C2 (ru) * 2004-01-23 2009-12-20 Корнелл Рисеч Фаундейшн, Инк. Способ уменьшения окислительного повреждения (варианты)
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US7804249B2 (en) * 2004-09-15 2010-09-28 Koninklijke Philips Electronics N.V. Light-transmitting substrate provided with a light-absorbing coating, light absorbing coating as well as method of preparing a light-absorbing coating
CA2947330C (en) * 2005-09-16 2018-06-05 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
US20070259377A1 (en) * 2005-10-11 2007-11-08 Mickey Urdea Diabetes-associated markers and methods of use thereof
US20080027082A1 (en) * 2006-06-19 2008-01-31 Berthold Hocher Use of adenosine a1 antagonists in radiocontrast media induced nephropathy
CA2669982A1 (en) * 2006-11-17 2008-05-29 Schering Corporation Combination therapy for proliferative disorders
CA2713150C (en) * 2008-02-07 2016-01-05 Cornell University Methods for preventing or treating insulin resistance
DK2262520T3 (en) * 2008-02-26 2017-08-07 Univ Cornell COMPOSITIONS FOR PREVENTION AND TREATMENT OF Kidney Injury
JP6005359B2 (ja) * 2008-08-28 2016-10-12 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 対象のサイズの変更を決定する装置
CN102573881A (zh) * 2009-03-20 2012-07-11 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法

Similar Documents

Publication Publication Date Title
JP2023002662A5 (enExample)
JP2020033360A5 (enExample)
JP2019503365A5 (enExample)
JP2008535867A5 (enExample)
JP2009102342A5 (enExample)
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
JP2013522303A5 (enExample)
JP2021530554A5 (enExample)
RU2013155509A (ru) Применение ингибирования катепсина к для лечения и/или профилактики легочной гипертензии и/или сердечной недостаточности
JP2015508765A5 (enExample)
JP2018531273A5 (enExample)
JP2021512921A5 (enExample)
JP2012525358A5 (enExample)
JP2020500868A5 (enExample)
JPS61286326A (ja) パ−キンソン病治療薬
WO2023155837A1 (zh) 具有镇痛和/或止痒功能的药物组合物及其用途
CN113876775B (zh) 一种青藤碱或其药物可接受的盐作为治疗动脉性肺动脉高压药物的用途
JP2019509309A5 (enExample)
JP2021506907A5 (enExample)
JP2013518061A5 (enExample)
JP2023523247A (ja) ウイルス感染症の治療のためのレニン－アンジオテンシン系（ｒａｓ）モジュレーター、それを含む医薬組成物、およびそれを用いた治療方法
PT1309322E (pt) Utilização de derivados do ácido 3-benzoílfenilacético para o tratamento de afecções da retina
JP5386478B2 (ja) パーキンソン病に伴う運動不全の治療のための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用
JP2022512158A5 (enExample)
RU2010154623A (ru) Производные 1-аминоалкилциклогексана для лечения расстройств сна